Literature DB >> 23296072

Structure-guided studies of the SHP-1/JAK1 interaction provide new insights into phosphatase catalytic domain substrate recognition.

Nilda L Alicea-Velázquez1, Jean Jakoncic, Titus J Boggon.   

Abstract

SHP-1 (PTPN6) is a member of the SHP sub-family of protein tyrosine phosphatases and plays a critical role in the regulation of the JAK/STAT signaling pathway. Previous studies suggested that SHP-1 contains a PTP1B-like second phosphotyrosine pocket that allows for binding of tandem phosphotyrosine residues, such as those found in the activation loop of JAK kinases. To discover the structural nature of the interaction between SHP-1 and the JAK family member, JAK1, we determined the 1.8Å co-crystal structure of the SHP-1 catalytic domain and a JAK1-derived substrate peptide. This structure reveals electron density for only one bound phosphotyrosine residue. To investigate the role of the predicted second site pocket we determined the structures of SHP-1 in complex with phosphate and sulfate to 1.37Å and 1.7Å, respectively, and performed anomalous scattering experiments for a selenate-soaked crystal. These crystallographic data suggest that SHP-1 does not contain a PTP1B-like second site pocket. This conclusion is further supported by analysis of the relative dephosphorylation and binding affinities of mono- and tandem-phosphorylated peptide substrates. The crystal structures instead indicate that SHP-1 contains an extended C-terminal helix α2' incompatible with the predicted second phosphotyrosine binding site. This study suggests that SHP-1 defines a new category of PTP1B-like protein tyrosine phosphatases with a hindered second phosphotyrosine pocket.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296072      PMCID: PMC3578099          DOI: 10.1016/j.jsb.2012.12.009

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  33 in total

Review 1.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

2.  Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics.

Authors:  Paul J Ala; Lucie Gonneville; Milton C Hillman; Mary Becker-Pasha; Min Wei; Brian G Reid; Ronald Klabe; Eddy W Yue; Brian Wayland; Brent Douty; Padmaja Polam; Zelda Wasserman; Michael Bower; Andrew P Combs; Timothy C Burn; Gregory F Hollis; Richard Wynn
Journal:  J Biol Chem       Date:  2006-08-17       Impact factor: 5.157

Review 3.  The use of structural biology in Janus kinase targeted drug discovery.

Authors:  Nilda L Alicea-Velázquez; Titus J Boggon
Journal:  Curr Drug Targets       Date:  2011-04       Impact factor: 3.465

4.  SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.

Authors:  B Cuevas; Y Lu; S Watt; R Kumar; J Zhang; K A Siminovitch; G B Mills
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

Review 5.  Protein tyrosine phosphatase function: the substrate perspective.

Authors:  Tony Tiganis; Anton M Bennett
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

6.  The Cys(X)5Arg catalytic motif in phosphoester hydrolysis.

Authors:  Z Y Zhang; Y Wang; L Wu; E B Fauman; J A Stuckey; H L Schubert; M A Saper; J E Dixon
Journal:  Biochemistry       Date:  1994-12-27       Impact factor: 3.162

7.  Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.

Authors:  M David; H E Chen; S Goelz; A C Larner; B G Neel
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

8.  Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages.

Authors:  Y G Yeung; Y Wang; D B Einstein; P S Lee; E R Stanley
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  5 in total

1.  X-ray transparent microfluidic platforms for membrane protein crystallization with microseeds.

Authors:  Jeremy M Schieferstein; Ashtamurthy S Pawate; Michael J Varel; Sudipto Guha; Ieva Astrauskaite; Robert B Gennis; Paul J A Kenis
Journal:  Lab Chip       Date:  2018-03-13       Impact factor: 6.799

Review 2.  The molecular regulation of Janus kinase (JAK) activation.

Authors:  Jeffrey J Babon; Isabelle S Lucet; James M Murphy; Nicos A Nicola; Leila N Varghese
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

3.  Drosophila SOCS36E negatively regulates JAK/STAT pathway signaling via two separable mechanisms.

Authors:  Wojciech Stec; Oscar Vidal; Martin P Zeidler
Journal:  Mol Biol Cell       Date:  2013-07-24       Impact factor: 4.138

4.  Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma.

Authors:  Christos Demosthenous; Jing Jing Han; Guangzhen Hu; Mary Stenson; Mamta Gupta
Journal:  Oncotarget       Date:  2015-12-29

Review 5.  Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.

Authors:  Riley D Metcalfe; Tracy L Putoczki; Michael D W Griffin
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.